{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:33:04Z","timestamp":1787563984793,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004835","name":"Zhejiang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031028","name":"Rajavithi Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012175","name":"Zhejiang Traditional Chinese Medicine Administration","doi-asserted-by":"publisher","award":["GZY-ZJ-KJ-24083"],"award-info":[{"award-number":["GZY-ZJ-KJ-24083"]}],"id":[{"id":"10.13039\/501100012175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ygyno.2026.06.012","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:57:22Z","timestamp":1782233842000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Diagnostic value of FAM19A4\/SOX1\/PAX1 methylation in non-16\/18 high-risk HPV cervical lesions"],"prefix":"10.1016","volume":"211","author":[{"given":"Peiyu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2026.06.012_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2026.06.012_bb0010","series-title":"WHO Guideline for Screening and Treatment of Cervical Pre-cancer Lesions for Cervical cancer Prevention: Use of Dual-Stain Cytology to Triage Women after a Positive Test for Human Papillomavirus (HPV)","author":"WHO Guidelines Approved by the Guidelines Review Committee","year":"2024"},{"issue":"3","key":"10.1016\/j.ygyno.2026.06.012_bb0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ijgc-2022-003703","article-title":"Updates on cervical cancer prevention","volume":"33","author":"Viveros-Carre\u00f1o","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.012_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/LGT.0000000000000529","article-title":"Risk estimates supporting the 2019 ASCCP risk-based management consensus guidelines","volume":"24","author":"Egemen","year":"2020","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ygyno.2026.06.012_bb0025","article-title":"Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study","volume":"26","author":"Ram\u00edrez","year":"2023","journal-title":"Lancet Reg. Health Am."},{"key":"10.1016\/j.ygyno.2026.06.012_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12907-017-0058-8","article-title":"Accuracy of cervical cytology: comparison of diagnoses of 100 pap smears read by four pathologists at three hospitals in Norway","volume":"17","author":"S\u00f8rbye","year":"2017","journal-title":"BMC Clin. Pathol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.06.012_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/cncy.22536","article-title":"Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: a large retrospective study from China","volume":"130","author":"Tao","year":"2022","journal-title":"Cancer Cytopathol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.012_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13148-020-00885-7","article-title":"DNA methylation for cervical cancer screening: a training set in China","volume":"12","author":"Kong","year":"2020","journal-title":"Clin. Epigenetics"},{"issue":"7","key":"10.1016\/j.ygyno.2026.06.012_bb0045","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/ijc.33430","article-title":"DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population","volume":"148","author":"Li","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2026.06.012_bb0050","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/jog.14869","article-title":"The application of PAX1 methylation detection and HPV E6\/E7 mRNA detection in cervical cancer screening","volume":"47","author":"Li","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"12","key":"10.1016\/j.ygyno.2026.06.012_bb0055","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1080\/15592294.2022.2080995","article-title":"ZNF582 promoter methylation predicts cervical cancer radiosensitivity and ZNF582 protein overexpression reduces radiosensitivity by cell cycle arrest in S phase","volume":"17","author":"Wu","year":"2022","journal-title":"Epigenetics"},{"key":"10.1016\/j.ygyno.2026.06.012_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3981529","article-title":"SOX1 and PAX1 are hypermethylated in cervical adenocarcinoma and associated with better prognosis","volume":"2020","author":"Zhao","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"3","key":"10.1016\/j.ygyno.2026.06.012_bb0065","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ygyno.2018.06.014","article-title":"Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer","volume":"150","author":"Rogeri","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2026.06.012_bb0070","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/IGC.0000000000001011","article-title":"PAX1 methylation as a potential biomarker to predict the progression of cervical intraepithelial neoplasia: a Meta-analysis of related studies","volume":"27","author":"Luan","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.012_bb0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.33320","article-title":"Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study","volume":"148","author":"Bonde","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.ygyno.2026.06.012_bb0080","article-title":"ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection","volume":"4","author":"Zhu","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ygyno.2026.06.012_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1051102","article-title":"An overview of PAX1: expression, function and regulation in development and diseases","volume":"10","author":"Wu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.012_bb0090","doi-asserted-by":"crossref","first-page":"9195","DOI":"10.1038\/s41598-019-45477-5","article-title":"Paired Box-1 (PAX1) activates multiple phosphatases and inhibits kinase cascades in cervical cancer","volume":"9","author":"Su","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2026.06.012_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109488","article-title":"Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma","volume":"120","author":"Tang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.012_bb0100","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13148-024-01804-w","article-title":"Evaluating PAX1\/JAM3 methylation for triage in HPV 16\/18-infected women","volume":"16","author":"Fei","year":"2024","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.012_bb0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13148-024-01731-w","article-title":"Triage performance of PAX1(m)\/JAM3(m) in opportunistic cervical cancer screening of non\u201316\/18 human papillomavirus-positive women: a multicenter prospective study in China","volume":"16","author":"Chen","year":"2024","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.012_bb0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ygyno.2013.07.111","article-title":"SOX1 suppresses cell growth and invasion in cervical cancer","volume":"131","author":"Lin","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.012_bb0115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/1471-0528.17965","article-title":"PAX1\/SOX1 DNA methylation versus cytology and HPV16\/18 genotyping for the triage of high-risk HPV-positive women in cervical Cancer screening: retrospective analysis of archival samples","volume":"132","author":"Chan","year":"2025","journal-title":"Bjog"},{"issue":"4","key":"10.1016\/j.ygyno.2026.06.012_bb0120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.32614","article-title":"FAM19A4\/miR124-2 methylation in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"147","author":"Vink","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2026.06.012_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29521","article-title":"Analysis of the diagnostic performance of PAX1\/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis","volume":"96","author":"Fan","year":"2024","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.ygyno.2026.06.012_bb0130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/IGC.0000000000000155","article-title":"PAX1 methylation as a potential biomarker for cervical cancer screening","volume":"24","author":"Kan","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2026.06.012_bb0135","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/cam4.2855","article-title":"Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions","volume":"9","author":"Leeman","year":"2020","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.ygyno.2026.06.012_bb0140","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/1471-0528.70162","article-title":"SOX1\/PAX1 methylation for triage of HPV-positive women in cervical cancer screening: a cohort study","volume":"133","author":"Xie","year":"2026","journal-title":"Bjog"},{"issue":"6","key":"10.1016\/j.ygyno.2026.06.012_bb0145","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ijc.31539","article-title":"Cervical cancer risk in HPV-positive women after a negative FAM19A4\/mir124-2 methylation test: a post hoc analysis in the POBASCAM trial with 14 year follow-up","volume":"143","author":"LMA","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2026.06.012_bb0150","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/ijc.29824","article-title":"Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16\/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study)","volume":"138","author":"Luttmer","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2026.06.012_bb0155","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1093\/cid\/ciac433","article-title":"FAM19A4\/miR124-2 methylation testing and human papillomavirus (HPV) 16\/18 genotyping in HPV-positive women under the age of 30 years","volume":"76","author":"Vink","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2026.06.012_bb0160","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"Dockter","year":"2009","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.012_bb0165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ygyno.2014.03.008","article-title":"Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China","volume":"133","author":"Pan","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.06.012_bb0175","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.2147\/CMAR.S254330","article-title":"The efficiency of type-specific high-risk human papillomavirus models in the triage of women with atypical squamous cells of undetermined significance","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.012_bb0180","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000538464","article-title":"PAX1 and SOX1 gene methylation as a detection and triage method for cervical intraepithelial neoplasia diagnosis","volume":"68","author":"Gao","year":"2024","journal-title":"Acta Cytol."},{"issue":"4","key":"10.1016\/j.ygyno.2026.06.012_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens13040312","article-title":"FAM19A4 and hsa-miR124-2 double methylation as screening for ASC-H- and CIN1 HPV-positive women","volume":"13","author":"Peronace","year":"2024","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.ygyno.2026.06.012_bb0195","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.012_bb0200","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1186\/s12885-024-12696-7","article-title":"Evaluating PAX1 methylation for cervical cancer screening triage in non-16\/18 hrHPV-positive women","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.012_bb0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41416-021-01614-4","article-title":"Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4\/miR124-2 methylation and HPV genotyping","volume":"126","author":"Dick","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2026.06.012_bb0210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2019.06.002","article-title":"Long-term CIN3+ risk of HPV positive women after triage with FAM19A4\/miR124-2 methylation analysis","volume":"154","author":"Dick","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2026.06.012_bb0215","doi-asserted-by":"crossref","first-page":"125.e1","DOI":"10.1016\/j.cmi.2020.03.018","article-title":"FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort","volume":"27","author":"Vink","year":"2021","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826020329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826020329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:35:28Z","timestamp":1786149328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826020329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"alternative-id":["S0090825826020329"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.06.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of FAM19A4\/SOX1\/PAX1 methylation in non-16\/18 high-risk HPV cervical lesions","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}